Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDUnicycive Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.20 | -$0.20 | -$0.20 |
| Q2 2024 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q3 2024 | 4 | -$0.20 | -$0.05 | -$0.09 |
| Q1 2025 | 3 | -$0.19 | -$0.04 | -$0.10 |
| Q2 2025 | 2 | -$0.14 | -$0.14 | -$0.14 |
| Q3 2025 | 2 | -$0.04 | -$0.04 | -$0.04 |
| Q4 2025 | 2 | -$0.01 | -$0.01 | -$0.01 |
| Q1 2026 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q2 2026 | 1 | $0.46 | $0.46 | $0.46 |
| Q3 2026 | 1 | $0.64 | $0.64 | $0.64 |
| Q4 2026 | 1 | $0.61 | $0.61 | $0.61 |
Unicycive Therapeutics, Inc. Earnings Date And Information
Unicycive Therapeutics, Inc. last posted its earnings results on Wednesday, August 14th, 2024. The company reported $-0.15 earnings per share for the quarter, topping analysts' consensus estimates of $-0.23 by $0.08. The company had revenue of 0 for the quarter and had revenue of 675,000 for the year. Unicycive Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.28 diluted earnings per share) and currently has a price-to-earnings ratio of -2.06. Unicycive Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based on prior year's report dates.
Unicycive Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.05 | $0 | $0 | ||
| 08/14/2024 | Q2 2024 | -$0.23 | $0.10 | 0.33 | $0 | $0 |
| 05/13/2024 | Q1 2024 | -$0.18 | -$0.60 | -0.42 | $0 | |
| 03/28/2024 | Q4 2023 | -$0.18 | -$0.22 | -0.04 | $-271,000 | |
| 11/14/2023 | Q3 2023 | -$0.13 | -$0.13 | 0 | $0 | |
| 08/14/2023 | Q2 2023 | -$0.39 | -$0.25 | 0.14 | $0 | |
| 05/16/2023 | Q1 2023 | -$0.36 | -$1.65 | -1.29 | $675,000 | |
| 03/30/2023 | Q4 2022 | $0.24 | -$0.35 | -0.59 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.35 | -$0.37 | -0.02 | $951,000 | |
| 08/15/2022 | Q2 2022 | -$0.27 | -$0.24 | 0.03 | $0 | |
| 05/12/2022 | Q1 2022 | -$0.20 | -$0.24 | -0.04 | $0 | |
| 03/31/2022 | Q4 2021 | -$0.13 | -$0.19 | -0.06 | $0 | |
| 11/10/2021 | Q3 2021 | -$0.37 | $0 | |||
| 08/16/2021 | Q2 2021 | -$0.11 | -$0.08 | 0.03 | $0 | |
| 03/30/2021 | Q1 2021 | -$0.07 | $0 | |||
| 12/31/2020 | Q4 2020 | -$0.06 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.08 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.04 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.04 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.08 | $0 |
Unicycive Therapeutics, Inc. Earnings: FAQ's
When is Unicycive Therapeutics, Inc.'s earnings date?
Unicycive Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 27th, 2025 based off last year's report dates.
Did Unicycive Therapeutics, Inc. beat their earnings estimates last
quarter?
In the previous quarter, Unicycive Therapeutics, Inc. (:UNCY) reported $-0.15 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.23 by $0.08.
How can I listen to Unicycive Therapeutics, Inc.'s earnings conference
call?
The conference call for Unicycive Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Unicycive Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Unicycive Therapeutics, Inc.'s latest earnings report can be read online.
How much revenue does Unicycive Therapeutics, Inc. generate each year?
Unicycive Therapeutics, Inc. (:UNCY) has a recorded annual revenue of $675,000.
How much profit does Unicycive Therapeutics, Inc. generate each year?
Unicycive Therapeutics, Inc. (:UNCY) has a recorded net income of $675,000. Unicycive Therapeutics, Inc. has generated $-1.28 earnings per share over the last four quarters.
What is Unicycive Therapeutics, Inc.'s price-to-earnings ratio?
Unicycive Therapeutics, Inc. (:UNCY) has a price-to-earnings ratio of -2.06 and price/earnings-to-growth ratio is -0.22.